EA201190286A1 - Адъювантные композиции, содержащие неионный агент, обеспечивающий изотоничность - Google Patents

Адъювантные композиции, содержащие неионный агент, обеспечивающий изотоничность

Info

Publication number
EA201190286A1
EA201190286A1 EA201190286A EA201190286A EA201190286A1 EA 201190286 A1 EA201190286 A1 EA 201190286A1 EA 201190286 A EA201190286 A EA 201190286A EA 201190286 A EA201190286 A EA 201190286A EA 201190286 A1 EA201190286 A1 EA 201190286A1
Authority
EA
Eurasian Patent Office
Prior art keywords
compositions containing
adjustent
unique agent
providing isotonicity
isotonicity
Prior art date
Application number
EA201190286A
Other languages
English (en)
Other versions
EA024074B1 (ru
Inventor
Вероник Эндерикс
Доминик Ингрид Лемуан
Original Assignee
Глаксосмитклайн Байолоджикалс С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40937237&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA201190286(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Глаксосмитклайн Байолоджикалс С.А. filed Critical Глаксосмитклайн Байолоджикалс С.А.
Publication of EA201190286A1 publication Critical patent/EA201190286A1/ru
Publication of EA024074B1 publication Critical patent/EA024074B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Предложены адъювантные и иммуногенные композиции, содержащие агонист TLR-4 и сапонин в липосомальной композиции, и неионный агент, обеспечивающий изотоничность, где концентрация хлорида натрия или ионная сила составляет менее 100 мМ.
EA201190286A 2009-06-10 2010-06-08 Водная адъювантная композиция, содержащая неионный агент, обеспечивающий изотоничность, иммуногенная композиция и набор на её основе и способ приготовления иммуногенной композиции EA024074B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0910046.2A GB0910046D0 (en) 2009-06-10 2009-06-10 Novel compositions
PCT/EP2010/058017 WO2010142685A1 (en) 2009-06-10 2010-06-08 Adjuvant compositions comprising a non-ionic isotonicity agent

Publications (2)

Publication Number Publication Date
EA201190286A1 true EA201190286A1 (ru) 2012-06-29
EA024074B1 EA024074B1 (ru) 2016-08-31

Family

ID=40937237

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201190286A EA024074B1 (ru) 2009-06-10 2010-06-08 Водная адъювантная композиция, содержащая неионный агент, обеспечивающий изотоничность, иммуногенная композиция и набор на её основе и способ приготовления иммуногенной композиции

Country Status (31)

Country Link
US (2) US20120087976A1 (ru)
EP (1) EP2440242B1 (ru)
JP (3) JP5647677B2 (ru)
KR (1) KR101473686B1 (ru)
CN (2) CN102458457B (ru)
AU (1) AU2010257538B2 (ru)
BR (1) BRPI1012890B1 (ru)
CA (1) CA2764421C (ru)
CL (1) CL2011003113A1 (ru)
CO (1) CO6440528A2 (ru)
CY (1) CY1115522T1 (ru)
DK (1) DK2440242T3 (ru)
DO (1) DOP2011000346A (ru)
EA (1) EA024074B1 (ru)
ES (1) ES2494442T3 (ru)
GB (1) GB0910046D0 (ru)
HR (1) HRP20140792T1 (ru)
IL (1) IL216231A0 (ru)
MA (1) MA33412B1 (ru)
MX (1) MX2011013162A (ru)
MY (1) MY159819A (ru)
NZ (1) NZ596503A (ru)
PE (1) PE20120319A1 (ru)
PL (1) PL2440242T3 (ru)
PT (1) PT2440242E (ru)
RS (1) RS53550B1 (ru)
SG (1) SG176638A1 (ru)
SI (1) SI2440242T1 (ru)
SM (1) SMT201400134B (ru)
UA (1) UA104888C2 (ru)
WO (1) WO2010142685A1 (ru)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2975024T3 (pl) 2009-06-10 2018-09-28 Chugai Seiyaku Kabushiki Kaisha Związki tetracykliczne
BR112013003879B1 (pt) 2010-08-20 2020-12-22 Chugai Seiyaku Kabushiki Kaisha composição compreendendo compostos tetracíclicos e formulação oralmente administrável que a compreende
CA2819297A1 (en) * 2010-12-14 2012-06-21 Glaxosmithkline Biologicals S.A. Mycobacterium antigenic composition
TR201815994T4 (tr) 2012-09-25 2018-11-21 Chugai Pharmaceutical Co Ltd Ret inhibitörü.
KR102242875B1 (ko) * 2014-03-25 2021-04-20 더 가번먼트 오브 더 유나이티드 스테이츠 오브 아메리카 에즈 리프리젠티드 바이 더 세크리터리 오브 더 아미 모노포스포릴 지질 a (mpla)-함유 리포솜 조성물 및 사포닌을 포함하는 무독성 아주반트 제제
CN106458967A (zh) 2014-04-25 2017-02-22 中外制药株式会社 四环化合物的新结晶
CN106456651A (zh) 2014-04-25 2017-02-22 中外制药株式会社 以高用量含有四环性化合物的制剂
TWI718102B (zh) 2014-08-08 2021-02-11 日商中外製藥股份有限公司 ４環性化合物的非晶質體
US11077093B2 (en) 2015-01-16 2021-08-03 Chugai Seiyaku Kabushiki Kaisha Combination drug
SG10202012205XA (en) 2015-11-06 2021-01-28 Adjuvance Technologies Inc Triterpene saponin analogues
CA3045952A1 (en) * 2016-12-07 2018-06-14 Glaxosmithkline Biologicals Sa Novel process
IL292991A (en) 2017-04-25 2022-07-01 Adjuvance Tech Inc Triterpene saponin analogs
JP2020521781A (ja) 2017-05-30 2020-07-27 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム リポソームに内包されたｒｎａを製造する方法
AU2018350887A1 (en) * 2017-10-16 2020-03-05 Adjuvance Technologies, Inc. Triterpene saponin analogues
EP3717005A1 (en) 2017-12-01 2020-10-07 GlaxoSmithKline Biologicals S.A. Saponin extraction
JP2021504424A (ja) 2017-12-01 2021-02-15 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム サポニン精製
EP3815688B1 (en) 2018-06-29 2023-12-06 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical composition containing poorly-soluble basic medicine
AU2019337018B2 (en) 2018-09-04 2024-03-07 Chugai Seiyaku Kabushiki Kaisha Method of producing tetracyclic compound
WO2020109365A1 (en) 2018-11-29 2020-06-04 Glaxosmithkline Biologicals Sa Methods for manufacturing an adjuvant
BR112021024363A2 (pt) 2019-06-05 2022-03-22 Glaxosmithkline Biologicals Sa Purificação de saponina
JP2022543264A (ja) * 2019-08-05 2022-10-11 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム プロテインｄポリペプチドを含む組成物を調製するプロセス
EP4021407A1 (en) 2019-08-30 2022-07-06 GlaxoSmithKline Biologicals S.A. Jet mixing lipid nanoparticle manufacturing process
EP4570269A4 (en) * 2023-03-15 2025-10-22 United Immunity Co Ltd LIPID PARTICLE
WO2025180443A1 (en) * 2024-02-29 2025-09-04 Immunadd Inc. Adjuvant composition, pharmaceutical composition comprising the same, and method for preventing or treating disease caused by viral infection, bacterial infection, protozoal infection or cancer

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804381A (en) 1996-10-03 1998-09-08 Cornell Research Foundation Isolated nucleic acid molecule encoding an esophageal cancer associated antigen, the antigen itself, and uses thereof
EP0689454B2 (en) * 1993-03-23 2005-02-23 SMITHKLINE BEECHAM BIOLOGICALS s.a. Vaccine compositions containing 3-o deacylated monophosphoryl lipid a
UA56132C2 (ru) * 1995-04-25 2003-05-15 Смітклайн Бічем Байолоджікалс С.А. Композиция вакцины (варианты), способ стабилизации qs21 по отношению к гидролизу (варианты), способ приготовления вакцины
DE19803453A1 (de) * 1998-01-30 1999-08-12 Boehringer Ingelheim Int Vakzine
TR200002284T2 (tr) 1998-02-05 2000-11-21 Smithkline Beecham Biologicals S.A. Mage ailesinden tümör ile ilgili tümör türevleri
DK1075276T3 (da) * 1998-05-07 2008-02-11 Corixa Corp Adjuvanssammensætning og fremgangsmåder til dens anvendelse
JP3765232B2 (ja) 2000-11-16 2006-04-12 株式会社ジェイテクト 電動式パワーステアリング装置及びこれに用いる歯車の製造方法
GB0409940D0 (en) 2004-05-04 2004-06-09 Glaxosmithkline Biolog Sa Vaccine
GB0411411D0 (en) * 2004-05-21 2004-06-23 Glaxosmithkline Biolog Sa Vaccines
EP1829887B1 (en) * 2004-11-29 2011-08-24 Changchun Huapu Biotechnology Co., Ltd. Cpg single-strand deoxynucleotides for use as adjuvant
US9486515B2 (en) * 2005-06-27 2016-11-08 Glaxosmithkline Biologicals S.A. Immunogenic composition
TWI457133B (zh) * 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
DK2114993T3 (da) 2007-01-15 2012-10-22 Glaxosmithkline Biolog Sa Vaccine
MX2009007572A (es) 2007-01-15 2009-10-13 Glaxosmithkline Biolog Sa Proteinas de fusion que contienen los antigenos de rechazo de tumor ny-eso-1 y.
CA2687632C (en) * 2007-05-24 2013-01-15 Glaxosmithkline Biologicals S.A. Lyophilised antigen composition
GB0910045D0 (en) * 2009-06-10 2009-07-22 Glaxosmithkline Biolog Sa Novel compositions

Also Published As

Publication number Publication date
AU2010257538A1 (en) 2011-12-08
EP2440242B1 (en) 2014-06-25
HRP20140792T1 (hr) 2014-10-10
WO2010142685A1 (en) 2010-12-16
PL2440242T3 (pl) 2014-11-28
MA33412B1 (fr) 2012-07-03
UA104888C2 (ru) 2014-03-25
KR101473686B1 (ko) 2014-12-18
RS53550B1 (sr) 2015-02-27
KR20120031497A (ko) 2012-04-03
PT2440242E (pt) 2014-08-29
DK2440242T3 (da) 2014-09-01
CO6440528A2 (es) 2012-05-15
AU2010257538B2 (en) 2016-10-20
CN104367997B (zh) 2019-01-22
CA2764421A1 (en) 2010-12-16
MY159819A (en) 2017-02-15
CL2011003113A1 (es) 2012-08-31
CY1115522T1 (el) 2017-01-04
CN102458457B (zh) 2015-05-20
JP2015042646A (ja) 2015-03-05
EP2440242A1 (en) 2012-04-18
CN104367997A (zh) 2015-02-25
BRPI1012890A2 (pt) 2018-02-27
CA2764421C (en) 2016-12-06
NZ596503A (en) 2013-08-30
JP5977789B2 (ja) 2016-08-24
EA024074B1 (ru) 2016-08-31
GB0910046D0 (en) 2009-07-22
SG176638A1 (en) 2012-01-30
BRPI1012890B1 (pt) 2022-03-22
DOP2011000346A (es) 2012-01-15
ES2494442T3 (es) 2014-09-15
MX2011013162A (es) 2012-01-30
JP2016193912A (ja) 2016-11-17
IL216231A0 (en) 2012-01-31
PE20120319A1 (es) 2012-04-16
JP5647677B2 (ja) 2015-01-07
US20120087976A1 (en) 2012-04-12
CN102458457A (zh) 2012-05-16
JP6261647B2 (ja) 2018-01-17
JP2012529464A (ja) 2012-11-22
US20180021417A1 (en) 2018-01-25
SI2440242T1 (sl) 2014-09-30
SMT201400134B (it) 2014-11-10

Similar Documents

Publication Publication Date Title
EA201190286A1 (ru) Адъювантные композиции, содержащие неионный агент, обеспечивающий изотоничность
UY33802A (es) Composiciones inmunógenas que comprenden un antígeno relacionado con M72 y que tienen una fuerza iónica baja
EA201190285A1 (ru) Иммуногенные композиции, имеющие низкую концентрацию хлорида натрия
BRPI0515316A (pt) compostos de imidazoquinolina
NO20064347L (no) Substituerte 1,2,3,4-tetrahydroisokinolinderivater
EA200801275A1 (ru) Стабилизированные составы карбоната лантана
NO20064584L (no) Tetrahydropyridoindolderivater
MX2010004389A (es) Formulaciones de vancomicina liposomales.
PE20080658A1 (es) Formulaciones de metilnaltrexona en forma de polvo seco
NZ602685A (en) Concentrated protein formulations and uses thereof
EA200700684A1 (ru) Полиаминные композиции
MX2010006370A (es) Composiciones de activo antitranspirante que tienen un cromatograma sec que exhibe una intensidad de pico 4 sec elevada.
TR200806298A2 (tr) Farmasötik formülasyon
SI1933809T1 (sl) Sestavki za mazalno dajanje
DE602005021770D1 (de) Indol-1-yl-essigsäurederivate
EA201200153A1 (ru) Сухая композиция для смешивания с водой (варианты), раствор для очищения кишечника на ее основе, водный раствор, набор, способ очищения толстой кишки
MX2018014631A (es) Formulacion de neurotoxina.
PE20140621A1 (es) Mejoras en o relacionadas con composiciones cementicias
AR089337A1 (es) Composiciones para el cuidado oral
TW200605872A (en) Alcohol-metabolism enhancing composition and ingesta containing the same
BR112015028824A2 (pt) composição de tensoativo concentrada
DOP2011000335A (es) Combinacion antitumoral que comprende ave8062 y sorafenib
EA200701172A1 (ru) 2-алкокси-3,4,5-тригидроксиалкиламиды, их получение, композиции, их содержащие, и применение
MX2023003847A (es) Composiciones y métodos prebióticos para el cuidado bucal.
UA93540C2 (ru) Фармацевтическая композиция для аэрозольного распыления c двумя действующими веществами и, по меньшей mepe, одним поверхностно-активным веществом

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ KG MD TJ TM